Succinate/SUCNR1 signaling amplifies macrophage inflammatory priming in atherosclerosis through the ERK–MYD88 axis
Authors:
Open Access
- 31 July 2026
- journal article
- Published by Elsevier in International Immunopharmacology
- Vol. 187, 117198
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Key Technologies Research and Development Program
This publication has 43 references indexed in Scilit:
- Succinate-mediated activation of the GPR91/MALT1/NF-κB/CCL2 pathway in macrophages contributes to pulmonary fibrosisInternational Immunopharmacology, 2026
- Inflammation in atherosclerosis: Lessons and therapeutic implicationsImmunity, 2025
- Decoding Toll-like receptors: Recent insights and perspectives in innate immunityImmunity, 2024
- Targeting the succinate receptor effectively inhibits periodontitisCell Reports, 2022
- The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathwaysCell Reports, 2022
- Extracellular succinate hyperpolarizes M2 macrophages through SUCNR1/GPR91-mediated Gq signalingCell Reports, 2021
- SUCNR1-mediated chemotaxis of macrophages aggravates obesity-induced inflammation and diabetesDiabetologia, 2017
- Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory MacrophagesCell, 2016
- Macrophages and immune cells in atherosclerosis: recent advances and novel conceptsBasic Research in Cardiology, 2015
- Macrophages in the Pathogenesis of AtherosclerosisCell, 2011